NCT06620406 - Synbiotic Therapy for NP-PASC | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 9, 2024

Primary Completion Date

August 6, 2025

Study Completion Date

August 6, 2025

Conditions

Post-Acute COVID-19 SyndromeLong COVID-19

Interventions

DIETARY_SUPPLEMENT

Synbiotic IVS-1

A mixture of the prebiotic potato resistant starch (RS, Bobs Red Mill) and the probiotic IVS-1 (Bifidobacterium adolescentis).

DIETARY_SUPPLEMENT

Maltodextrin

Maltodextrin, a carbohydrate packaged similarly to the study intervention

Trial Locations (1)

Columbia University Irving Medical Center, New York

All Listed Sponsors

lead

Columbia University

OTHER